Compare IFRX & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IFRX | BIOX |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | Germany | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.0M | 61.5M |
| IPO Year | 2017 | N/A |
| Metric | IFRX | BIOX |
|---|---|---|
| Price | $0.83 | $0.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $8.50 | $4.33 |
| AVG Volume (30 Days) | 609.3K | ★ 868.6K |
| Earning Date | 03-19-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $73,729.00 | ★ $318,158,904.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,054.36 | $37.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.71 | $0.56 |
| 52 Week High | $2.77 | $6.86 |
| Indicator | IFRX | BIOX |
|---|---|---|
| Relative Strength Index (RSI) | 36.10 | 20.16 |
| Support Level | $0.88 | $0.56 |
| Resistance Level | $1.01 | $1.30 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 8.87 | 1.81 |
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.